Aus coViki
Wechseln zu: Navigation, Suche
  • GET ä. Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19 Extract
  • GET 2020. Type 1 interferons as a potential treatment against COVID-19 Extract
  • GET 2020. Antiviral activities of type I interferons to SARS-CoV-2 infection Extract
  • GET 2020. COVID-19 and emerging viral infections: The case for interferon lambda Extract
  • GET 2020. COVID-19: lambda interferon against viral load and hyperinflammation Extract
  • GET 2011. (x)Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model Extract
  • GET 2020. Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a. Extract
  • GET 2020. COVID-19, interferons, and depression: A commentary. Extract
  • GET 2020. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Extract
  • GET 2020. Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19. Extract
  • GET 2020. Arbidol/IFN-alpha2b therapy for patients with corona virus disease 2019: a retrospective multicenter cohort study. Extract
GET 2020. Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19. Extract
  • GET 2020. Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells. Extract
  • GET 2020. Interferon beta-1a for COVID-19: critical importance of the administration route. Extract
  • GET 2020. Interferon-beta 1a inhibits SARS-CoV-2 in vitro when administered after virus infection. Extract
  • GET 2020. Interferon beta-1b for COVID-19. Extract
  • GET 2020. Inhibition of SARS-CoV-2 by type I and type III interferons. Extract
  • GET 2020. Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Extract
  • GET 2020. Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon beta-1b. Extract
  • GET 2020. Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy? Extract
  • GET 2020. Interferon-alpha2b Treatment for COVID-19. Extract
Meine Werkzeuge